The Global RNA Interference Drug Delivery Market is projected to reach US$8.39 billion by 2034, up from US$1.72 billion in 2025, expanding at a CAGR of 19.27% during the forecast period 2026–2034. Market growth is being driven by increasing investment in RNA-based therapeutics, rising demand for targeted drug delivery, advancements in nucleic acid technologies,...